SBWire

Bonovo Orthopedics, Inc. (Bonovo) is a medical device manufacturing company. The company develops, manufactures orthopedic implants and other orthopedic products to the Chinese healthcare market. Its products include spine (cervical), spine (thoracolumbar), joints, biologics, minimally invasive surgery products, surgical headlights, and instruments and other devices. Bonovo's instruments and other devices include surgical instruments and case, rod bender, rod gripper, distraction and compression pliers, and quick-change handle. The company provides services, such as product positioning and market analysis, testing and validation, manufacturing, marketing and distribution, and product support and training. The company markets products through its distributors. Bonovo is headquartered in Bloomington, Minnesota, the US.

Oxford Gene Technology (OGT) is a biotechnology company. The company develops biomarkers. Its products include CytoSure heamatological cancer +SNP Array, CytoSure ISCA arrays, CytoSure ISCA +SNP Array, CytoSure ISCA UPD array, CytoSure ISCA sample tracking spike-ins and CytoSure syndrome Plus v2 array. OGT offers services, such as targeted sequencing services, SureSeq Solid Tumour Panel Sequencing Service, RNA-Seq service, miRNA analysis, gene expression analysis, cytosure services and aCGH for CNV analysis. The company's customers include Agilent Technologies, University of Cambridge, Cancer Research UK, Alberta Children's Hospital, Bioarray and many more. OGT is headquartered in Begbroke, Oxfordshire, the UK.

Terumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing and selling of a wide range of innovative medical care products which include hospital and medical products, equipment and pharmaceuticals. Its major products include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusions systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products. The company conducts its operations in three divisions, namely, General Hospital business, Cardiac and Vascular business, and Blood Management business. Terumo conducts its operations through subsidiaries and associates across Japan, Europe, America and Asia-Pacific. The company is headquartered in Tokyo, Japan.

JenaValve Technology GmbH (JenaValve) is a medical device company. The company designs and develops minimally invasive heart valve replacement systems for the cardiovascular markets. It concentrates on the development of transcatheter systems. JenaValve's product, jenavalve transcatheter aortic valve implantation system is used in transapical and transfemoral implantation. Its TAVI system comprises jeanvalve, a porcine root valve sewn onto a Nitinol self-expanding stent; and Cathlete delivery system. The company develops products through its TAVI technology. It provides services such as technology development, design process and device engineering. JenaValve is headquartered in Munich, Bayern, Germany.

GlobalData's new report, "Russia General Surgery Outlook to 2020", provides key market data on the Russia General Surgery Procedures. The report provides procedure volumes within market segments - Airway Stenting Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Capsule Endoscopy Procedures, Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Female Sterilization Procedures, Gastric Balloon Procedures, Gastrointestinal (GI) Stenting Procedures, Hernia Repair Procedures, Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting Procedures, Pyeloplasty Procedures, Resectoscopy - Procedures using Resectoscope Electrodes, Transurethral Resection of the Prostrate (TURP) Procedures, Urinary Tract Stenting Procedures and Uterine Fibroid Embolization (UFE) Procedures.

GlobalData's new report, "China General Surgery Outlook to 2020", provides key market data on the China General Surgery Procedures. The report provides procedure volumes within market segments - Airway Stenting Procedures, Bariatric Surgery Procedures, Biopsy Procedures, Capsule Endoscopy Procedures, Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures, Female Sterilization Procedures, Gastric Balloon Procedures, Gastrointestinal (GI) Stenting Procedures, Hernia Repair Procedures, Percutaneous Transhepatic Cholangiography (PTC) Biliary Stenting Procedures, Pyeloplasty Procedures, Resectoscopy - Procedures using Resectoscope Electrodes, Transurethral Resection of the Prostrate (TURP) Procedures, Urinary Tract Stenting Procedures and Uterine Fibroid Embolization (UFE) Procedures.

Consort Medical plc (Consort Medical) is a healthcare company with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostics. The company categorizes its products three major types, namely, respiratory dry powder inhalers (DPI); respiratory metered dose inhalers (MDI); and others. Major products offered by Consort Medical include metered dose inhalers, dry powder devices, integrated dose counters, actuators, auto-injectors, nasal drug delivery devices, nicotine inhalation devices, POC diagnostics devices, and medical check valves among others. Further, it holds a development portfolio of auto-injectors, nicotine delivery systems, nasal devices, and infusion systems among others. The company offers its products to global pharmaceutical companies in the UK, the US, Europe, and other parts of the world through its subsidiaries and distributors. The company is headquartered in Hemel Hempstead, England, the UK.

Tissue Regenix Ltd (Tissue Regenix) is a medical technology company. The company makes replacement body parts from biological (animal) materials by using proprietary platform, known as the dCELL technology platform. Its proprietary dCELL technology process is applied in markets, such as vascular, cardiac and orthopaedics. In addition, the company manufactures dCELL vascular patch which is its main product. Its other products include dCELL (Human) heart valve, additional applications for the dCELL patch, dCELL meniscus and dCELL (Human) dermis. The company operates through its distributor Nuros Limited in the UK. Tissue Regenix is headquartered in Heslington, York, the UK.

OPERON S.A. (Operon) is a biotechnology company. The company develops and manufactures products in the field of immunochemistry. Its products include raw materials, rapid test, ELISA kits, molecular diagnostic products, rotavirus, norovirus, chagas, CD2WB, chagas WB, lisaKIT PSA, lisaKIT AFP, lisaKIT toxo IgG, HLA B5701 strip, HPV - low risk, HPV - high+low risk, hemochromastrip and others. Operon offers services, such as manufacturing in OEM format, and lateral flow tests. The company's research and development facility develops ELISA and monoclonal antibodies, immunochromatographic products, molecular diagnostic products and recombinant antigens. It markets its products through distributors in Austria, Chile, France, Belgium, Greece, Ireland, Italy, Kenya, Mexico, Poland, Turkey and Peru, among others. Operon is headquartered in Cuarte Of Huerva, Zaragoza, Spain.

Asia-Pacific Ureteroscopes Market Outlook to 2020

GlobalData's new report, "BRIC Hernia Repair Market Outlook to 2020", provides key market data on the BRIC Hernia Repair market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Meshes (Synthetic Flat Meshes and Synthetic 3D Meshes), Composite Meshes and Biological Meshes.

Proplex Technologies, Llc (Proplex Technologies) is a biotechnology company. The company concentrates on the discovery of protein biomarkers in human diseases. Its biomarkers are used in the early detection of cancer and monitoring the effectiveness of cancer treatment. Proplex Technologies's 2D HPLE technology is a two-dimensional polyacrylamide gel electrophoresis used in applications to identify critical biomarkers in several human diseases. The company's technology is also used in identifying several types of breast cancer and other human disease biomarkers. Its product Biomarker B-4 is in stage II of clinical trial. Proplex Technologies is headquartered in Dresher, the US.

GlobalData's new report, "BRIC Endoscopy Fluid Management Systems Market Outlook to 2020", provides key market data on the BRIC Endoscopy Fluid Management Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Laparoscopy Fluid Management Systems and Hysteroscopy Fluid Management Systems.

Japan Hernia Repair Market Outlook to 2020

Japan Resectoscopes Market Outlook to 2020

Canada Hernia Repair Market Outlook to 2020

South Korea Bronchoscopes Market Outlook to 2020

Hycor Biomedical Inc. (Hycor) is an in vitro diagnostics products manufacturer and marketer. The company manufactures and markets systems and testing products for in vitro allergy and autoimmune disorders. Its products include ultra-sensitive EIA system, ELISA microplate assay kits, 288 plus system, reagents, allergy products, urinalysis products, and serology reagents. Hycor provides serology assays for detection of antibodies to target organisms. The company provides organ-specific, systemic, ENA-6 tests, DNA, anti-nuclear cytoplasmic, phospholipid, rheumatoid factor, celiac disease autoantibodies, and bulk reagents and components for autoimmune applications. It markets its products through the brand names such as Hycor and Autostat. The company has operations in Garden Grove, California and Kassel. Hycor is headquartered in Garden Grove, California, the US.

Spain Hernia Repair Market Outlook to 2020

Germany Resectoscopes Market Outlook to 2020

South Korea Resectoscopes Market Outlook to 2020

Biocrates Life Sciences AG (Biocrates) is a biotechnology company. The company develops metabolomic products and vitro diagnostics (IVDs) for early disease detection. Its metabolomic solutions set a new level of standardized data processing, exchange, and storage, which can readily meet the rigorous demands of various disciplines such as life sciences, personalized medicine, clinical research, nutrition research, and pharmaceutical drug development. The company's products include absolute IDQ P150, stero 17 kit, steroid reagent kit, and stero IDQ kit. It caters its products to Chenomox, Hamilton, Pfize, Gene Go and V&F. The company markets its products to Denmark, Spain, Sweden, Finland, Norway and Iceland. Biocrates is headquartered in Innsbruck, Austria.

XDx, Inc. (XDx) is a molecular diagnostics company. The company discovers, develops, and commercializes clinically differentiated and non-invasive tests to monitor immune status in transplant recipients and autoimmune disease and potentially improve long-term patient outcomes. It commercializes AlloMap molecular expression testing, which aids clinicians in identifying heart transplant recipients with stable graft function. XDx applies genomics and bioinformatics technology to develop molecular diagnostic assays based on gene expression patterns in blood cells that provide clinically useful information. It partners and collaborates with pharmaceutical and biotech companies, medical centers, and academic institutions in developing biological markers. XDx is headquartered in Brisbane, California, the US.

GlobalData's new report, "Spain Bronchoscopes Market Outlook to 2020", provides key market data on the Spain Bronchoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Video Bronchoscopes (Flexible Video Bronchoscopes and Portable Video Bronchoscopes) and Non-Video Bronchoscopes (Rigid Non-Video Bronchoscopes and Flexible Non-Video (Fibre) Bronchoscopes).

Menssana Research, Inc. (Menssana) is a research organization. The organization develops breath tests for the detection of diseases. The company's breath test is being evaluated in various clinical studies such as lung cancer, breast cancer, heart transplant rejection, kidney disease, ischemic heart disease, diabetes mellitus, and development of the next-generation BCA. Menssana has developed a point-of-care breath-testing system, BreathLink, which collects concentrates and analyzes a breath sample. It also offers lab analysis services. The organization operates through its breath centers in Washington, California, Pennsylvania, Florida, the US and the Netherlands. Menssana is headquartered in Fort Lee, New Jersey, the US.